Colon competition ....... FYI
I own IMMU. They just fired Mallinckrodt last week.
Some are guessing that IMMU will use Lily to
market CEA-SCAN.
I think NMPS should be able to beat them in the
market place.
Regards,
John
==========================================
FDA Approves Mallinckrodt's Colorectal Cancer
Test
July 02, 1996
ST. LOUIS (AP) - A colorectal cancer test by Mallinckrodt Group Inc. has been approved by the U.S. Food and Drug
Administration.
The test was invented by Immunomedics Inc., a small drug company in Morris Plains, N.J. Mallinckrodt holds the U.S.
and European marketing rights. Immunomedics said 55,000 Americans die each year from colorectal cancer, and 138,000
new cases of the disease are discovered each year.
The test, called CEA-Scan, is an injectable liquid containing a radioactive element that attaches to cancerous tumors.
These tumors are then detected by physicians using an electronic camera to highlight the radioisotope.
The FDA said this test should be used in conjunction with a CT scan, the current diagnostic standard. When the CT scan -
a sophisticated and detailed type of X-ray - and CEA-Scan are used together, the tumor detection rate was 97 percent
effective, Immunomedics said.
It is working on similar products for identifying tumors of the breast and lung. The test is the company's first product.
Mallinckrodt already makes and sells OctreoScan, a radioactive drug that highlights cancerous tumors in the stomach,
lungs and thyroid. It is studying other cancer detection uses for this product.
The approval of CEA-Scan was announced Monday. |
